CXCL12 deficiency promotes colorectal cancer progression and reduces anti-PD-L1 immunotherapy efficacy through MDSC regulation

Heping Zhao(Sun Yat-sen University), Xing Chen(Nantong University), Yuhan Wang(Shanxi Medical University), Yunfeng Liu(Shanxi Medical University), Xiaonan Wang(Tongji University), Jie Zhang, Yao Tian(Shanxi Medical University), Sainan Liu(Central South University), Lijun Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiuqin An(Shanxi Medical University), Meimei Wei(Shanxi Medical University), Junni Wei(Shanxi Medical University)
Journal of Translational Medicine
December 5, 2025
Cited by 1


Related Papers